Compass Pathways
CMPS
103 hedge funds and large institutions have $81.1M invested in Compass Pathways in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 25 increasing their positions, 23 reducing their positions, and 12 closing their positions.
33% more capital invested
Capital invested by funds: $61M → $81.1M (+$20.1M)
1.29% more ownership
Funds ownership: 17.85% → 19.14% (+1.3%)
9% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 23
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
7% less funds holding
Funds holding: 111 → 103 (-8)
23% less call options, than puts
Call options by funds: $2.57M | Put options by funds: $3.33M
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$12.1M |
| 2 |
State Street
Boston,
Massachusetts
|
+$811K |
| 3 |
Barclays
London,
United Kingdom
|
+$766K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$710K |
| 5 |
SCM
Saba Capital Management
New York
|
+$694K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$2.43M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.38M |
| 3 |
Morgan Stanley
New York
|
-$2.16M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.54M |
| 5 |
Renaissance Technologies
New York
|
-$1.5M |
CMPS Hedge Fund Activity: Q1 2023 in Review
103 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Compass Pathways (CMPS) for Q1 2023, worth a combined $81.1M — up 33% from $61M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of CMPS and 7 opened new positions — a net loss of 5 holders — while 23 trimmed existing stakes and 25 added.
The largest buyer was ARK Investment Management, adding an estimated $12.1M. The largest seller was PFM Health Sciences, cutting an estimated $2.43M.
- 103 institutional investors held Compass Pathways (CMPS) as of Q1 2023, down from 111 in Q4 2022.
- Funds reported $81.1M of Compass Pathways stock for Q1 2023, up 33% quarter-over-quarter.
- 7 funds opened new Compass Pathways positions in Q1 2023 and 12 closed out, a net change of -5 holders.
- The largest Compass Pathways buyer in Q1 2023 was ARK Investment Management, an estimated $12.1M added.
- The largest Compass Pathways seller in Q1 2023 was PFM Health Sciences, an estimated $2.43M sold.
Based on aggregated 13F filings for Q1 2023.